Contributions of mitogen-activated protein kinase and nuclear factor kappa B toN-(4-hydroxyphenyl)retinamide-induced apoptosis in prostate cancer cells
- 29 October 2002
- journal article
- research article
- Published by Wiley in Molecular Carcinogenesis
- Vol. 35 (3) , 127-137
- https://doi.org/10.1002/mc.10084
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- MEK Inhibition Enhances Paclitaxel-induced Tumor ApoptosisJournal of Biological Chemistry, 2000
- VEGF Prevents Apoptosis of Human Microvascular Endothelial Cells via Opposing Effects on MAPK/ERK and SAPK/JNK SignalingExperimental Cell Research, 1999
- Phase II Chemoprevention Trial of Oral Fenretinide in Patients at Risk for Adenocarcinoma of the ProstateAmerican Journal of Clinical Oncology, 1997
- NF-κB: Ten Years AfterCell, 1996
- Induction of apoptosis by fenretinide (4HPR) in human ovarian carcinoma cells and its association with retinoic acid receptor expressionInternational Journal of Cancer, 1996
- Opposing Effects of ERK and JNK-p38 MAP Kinases on ApoptosisScience, 1995
- Retinoids in Cancer ChemopreventionAnnals of the New York Academy of Sciences, 1995
- Control of IκB-α Proteolysis by Site-Specific, Signal-Induced PhosphorylationScience, 1995
- Inhibition of proliferation and induction of apoptosis in cervical carcinoma cells by retinoids: Implications for chemopreventionJournal of Cellular Biochemistry, 1995
- Five-year administration of fenretinide: pharmacokinetics and effects on plasma retinol concentrations.Journal of Clinical Oncology, 1993